News Detail

Marijn Dekkers to Join BioQ Pharma’s Board of Directors

Jan 09, 2020

SAN FRANCISCO, CA, January 8, 2020: BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has agreed to join the Company’s board of directors.

Dr. Dekkers is founder and chairman of Novalis LifeSciences, an investment and advisory firm for the life science industry. He served as CEO of Bayer AG, a global life sciences company, from 2010 to 2016 and as CEO of Thermo Fisher Scientific Inc., a global leader in the manufacturing of laboratory instruments, from 2002 to 2009. Originally from The Netherlands, Dr. Dekkers started his career as a scientist at General Electric. He holds a Ph.D. and M.S. in chemical engineering from the University of Eindhoven and a B.S. in chemistry from the Radboud University, both in The Netherlands.

Josh Kriesel, President and CEO of BioQ Pharma, said, “We are honored to have Dr. Dekkers join our board of directors. He is a trusted advisor to the Company and a skilled operator. Dr. Dekkers’ many years of leading life science companies brings to BioQ’s board tremendous value and strategic insights.”

Marijn Dekkers commented, “I have gotten to know BioQ’s business well over the last 18 months and am very enthusiastic about the Company’s infusion technology and its many applications. I am looking forward to helping the board grow the business and to continuing to provide strategic counsel as the Company accelerates its commercial ramp.”

About BioQ Pharma

BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Stada, Cipla, Lee's Pharm, Lunatus, POA Pharma, Avanos Medical, Sophos Biotech, Lenis Pharma, Cooper Pharma, and West Pharmaceutical Services.

Company Contact Information:

Josh Kriesel
BioQ Pharma
President and CEO

Ron Pauli
BioQ Pharma
Chief Financial Officer